Search for: "Peters v. Barr" Results 61 - 80 of 100
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jul 2020, 3:53 am by Edith Roberts
In Little Sisters of the Poor Saints Peter and Paul Home v. [read post]
15 Mar 2008, 7:00 am
  Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to adopt… [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle),… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
29 Feb 2008, 8:00 am
, (EDTexweblog.com), (Patent Prospector), (Peter Zura's 271 Patent Blog), (IPBiz), (Against Monopoly), (Philip Brooks), (IPBiz), Indian government to consider whether to grant compulsory licenses to Natco for the exportation of generic versions of Tarceva and Sutent (Sunitinib) to Nepal : (Spicy IP), (Spicy IP), (Spicy IP), (Generic Pharmaceuticals & IP), (IP Law360), (Spicy IP),GlobalGlobal - GeneralIntellectual privilege or imaginary property? [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars Technica),… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
6 Jun 2008, 6:49 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: YouTube – Prince demands removal of song from YouTube, Radiohead demand it is put back online: (Techdirt), (Electronic Frontier Foundation), (The Trademark Blog), Japan planning fair use provision: (Michael Geist), (Techdirt), (IP Justice), (Patry Copyright Blog), Judge rejects Yoko Ono’s request for preliminary injunction… [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries… [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
7 Mar 2008, 2:00 am
UK Ltd clarifies law on keywords and sponsored search results: (IPKat), (Class 46), (Out-Law), Discussion of the End Software Patents initiative: (Peter Zura's 271 Patent Blog), (IAM), (IAM), (Patent Prospector), (IAM), (Securing Innovation), Global Global - General IP valuation – a Pandora’s box? [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
2 May 2008, 7:00 am
: (Spicy IP), Ultracet (Tramadol) – Barr and Caraco win summary judgment that Ortho-McNeil’s formulation patent on Ultracet is invalid: (Orange Book Blog), Xopenex (Levosalbutamol) – US: Sepracor, Breath settle Xopenex patent fight: (IP Law360), (GenericsWeb), Africa African copyright & access to knowledge (ACA2K) project launched: (Michael Geist), (Afro-IP), Seven reasons why Prof Odek should be the next WIPO DG: (Afro-IP), … [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty) Ltd:… [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
14 Jan 2020, 9:07 am by John Elwood
Barr, 19-307Issue: Whether district courts have inherent authority to release grand jury materials in extraordinary circumstances, such as when the case is historically significant and the public interest strongly favors disclosure. [read post]